1
|
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JF, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J, Prud'Homme M, Phillips GM, Smith SG, Ibrahim M, Willoughby CD, Obray JB, Gupta M, Paez J, Berg AP, Harrison NJ, Maino P, Mambalam P, McCarty M, Towlerton G, Love-Jones S, Ahmed S, Lee A, Shah B, Goor-Aryeh I, Russo MA, Varela N, Phelps JB, Cid J, Fernandez T, Pérez-Hernández C, Keehn D, Rosenow JM, Haider N, Parrent AG, Lawrence MM, Georgius P, Demartini L, Mendiola A, Mehta V, Thoma R, Israel AF, Carolis GD, Bhatia S, Green M, Villarreal A, Crooks MT, Gwinn RP, Pilitsis JG, Sato H, Vega SM, Hillegass MG, Carnes P, Scherer C, Brill S, Yu J, Brennan JJ, Gatzinsky K, Navani A, Snook LT, Bujedo BM, Andrés Ares JD, Murillo A, Trobridge AT, Assil K, Shah J, McLeod C, Buwembo J, Coster OD, Miller N, Sanapati M, Mikhael M, Przkora R, Sukenaga N, Raso LJ, Calodney AK, Cáceres Jerez LE, Uchiyama T, Kallewaard JW, Chandler B, Piedimonte F, Candido KD, Weaver TE, Agari T, Holthouse D, Woon R, Patel N, Lechleiter K, Jain R. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain. Pain Manag 2023; 13:115-127. [PMID: 36691862 DOI: 10.2217/pmt-2022-0091] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Aim: The availability of long-term (>2 years) safety outcomes of spinal cord stimulation (SCS) remains limited. We evaluated safety in a global SCS registry for chronic pain. Methods: Participants were prospectively enrolled globally at 79 implanting centers and followed out to 3 years after device implantation. Results: Of 1881 participants enrolled, 1289 received a permanent SCS implant (1776 completed trial). The annualized rate of device explant was 3.5% (all causes), and 1.1% due to inadequate pain relief. Total incidence of device explantation >3 years was 7.6% (n = 98). Of these, 32 subjects (2.5%) indicated inadequate pain relief as cause for removal. Implant site infection (11 events) was the most common device-related serious adverse event (<1%). Conclusion: This prospective, global, real-world study demonstrates a high-level of safety for SCS with low rate of explant/serious adverse events. Clinical Trial Registration: NCT01719055 (ClinicalTrials.gov).
Collapse
Affiliation(s)
- Richard L Rauck
- Carolinas Pain Institute & The Center for Clinical Research LLC, Winston-Salem, NC 27103, USA
| | | | - Simon J Thomson
- Mid & South Essex University Hospitals, Basildon, Essex, SS16 5NL, United Kingdom
| | | | - Louis Bojrab
- Forest Health Medical Center, Ypsilanti, MI 48198, USA
| | - John Noles
- Spine & Pain Specialists, Shreveport, LA 71105, USA
| | - Jan Vesper
- University Hospital Düsseldorf, Düsseldorf, 40225, Germany
| | | | - Daniel Roth
- Summit Pain Management, Fort Wayne, IN 46804, USA
| | - Joseph Hegarty
- Optim Health System - Tattnall Hospital, Reidsville, GA 30453, USA
| | | | | | - Stephen G Smith
- Ramos Center for Interventional & Functional Pain Medicine, Englewood, FL 34205, USA
| | - Mohab Ibrahim
- University of Arizona, Banner Health - University Medical Center, Tucson, AZ 85719, USA
| | | | - Jon B Obray
- Southwest Spine & Pain Center, St George, UT 84790, USA
| | - Mayank Gupta
- Kansas Pain Management & Neuroscience Research Center, LLC, Overland Park, KS 66210, USA
| | - Julio Paez
- Southlake Pain Institute, Clermont, FL 34711, USA
| | | | | | - Paolo Maino
- Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, 6900, Switzerland
| | | | | | - Glyn Towlerton
- Chelsea & Westminster Hospitals, London, SW10 9NH, United Kingdom
| | | | - Shakil Ahmed
- Weill Cornell Medicine, Center for Comprehensive Spine Care, New York City, NY 10022, USA
| | - Albert Lee
- Tallahassee Neurological Clinic, Tallahassee, FL 32308, USA
| | - Binit Shah
- Carolinas Pain Center, Charlotte, NC 28262, USA
| | - Itay Goor-Aryeh
- Pain Medicine Institute, Sheba Medical Center, Ramat Gan, 52621, Israel
| | - Marc A Russo
- Hunter Pain Specialists, Broadmeadow, New South Wales, 2292, Australia
| | | | | | - José Cid
- Toledo University Hospital Complex, Toledo, 45004, Spain
| | - Tacson Fernandez
- Royal National Orthopaedic Hospital, NHS Trust, Stanmore, Middlesex, HA7 4LP, United Kingdom
| | | | - Douglas Keehn
- Pain Centers of Wisconsin, Fort Atkinson, WI 53220, USA
| | - Joshua M Rosenow
- Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
| | - Nameer Haider
- APMR Spinal & Skeletal Pain Medicine, Utica, NY 13502, USA
| | - Andrew G Parrent
- London Health Sciences Centre, Western University, London, ON, N6A 5W9, Canada
| | | | - Peter Georgius
- Sunshine Coast Clinical Research, Noosa Heads, Queensland, 4567, Australia
| | | | - Agustin Mendiola
- Puerta de Hierro University Hospital, Boadilla del Monte, 28222, Spain
| | - Vivek Mehta
- St. Bartholomew's Hospital, London, EC1A 7BE, United Kingdom
| | | | - Atef F Israel
- Pain Management Associates, Lee's Summit, MO 64086, USA
| | | | - Sanjay Bhatia
- West Virginia University Neurosurgery, Morgantown, WV 26506, USA
| | - Matthew Green
- Pain Medicine of South Australia, Wayville, South Australia, 5034, Australia
| | | | | | - Ryder P Gwinn
- EvergreenHealth Neurosurgery, Kirkland, WA 98034, USA
| | - Julie G Pilitsis
- Charles E Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA
| | - Hitoaki Sato
- Kobe University Hospital, Kobe City, Hyōgo, 650-0017, Japan
| | | | | | - Paul Carnes
- Raleigh Neurology Associates, Raleigh NC 27607, USA
| | | | - Silviu Brill
- Sourasky Medical Center, Tel Aviv, 6423914, Israel
| | - James Yu
- Sydney Spine & Pain, Hurstville, NSW, 2220, Australia
| | - James J Brennan
- Sentara Neurosurgery Specialists, Virginia Beach, VA 23454, USA
| | | | - Annu Navani
- Comprehensive Spine & Sports Center, Campbell, CA 95008, USA
| | - Lee T Snook
- Metropolitan Pain Management Consultants, Sacramento, CA 95821, USA
| | | | | | - Abel Murillo
- AMPM Research Clinic, Miami Gardens, FL 33169, USA
| | | | - Kamyar Assil
- Conejo Pain Specialists Medical Group, Thousand Oaks, CA 91360, USA
| | - Jawad Shah
- Insight Neurosurgery, Dearborn Heights, MI 48091, USA
| | - Carroll McLeod
- Mississippi Sports Medicine & Orthopaedic Center, Jackson, MS 39110, USA
| | - Joseph Buwembo
- University of Saskatchewan College of Medicine, Saskatoon, SK, S7N 5E5, Canada
| | | | - Nathan Miller
- Coastal Pain & Spinal Diagnostics, Carlsbad, CA 92009, USA
| | | | | | - Rene Przkora
- University of Florida Health, Gainesville, FL 32610, USA
| | - Norihiko Sukenaga
- Hyōgo College of Medicine Hospital, Nishinomiya, Hyōgo, 663-8501, Japan
| | | | | | | | - Takuya Uchiyama
- Kindai University, Faculty of Medicine, Osaka-sayama, Osaka, 577-8502, Japan
| | | | | | | | | | - Tristan E Weaver
- The Ohio State University Medical Center, Columbus, OH 43210, USA
| | - Takashi Agari
- Tokyo Metropolitan Neurological Hospital, Tokyo, 150-0013, Japan
| | - David Holthouse
- Green Lizard Science, Claremont, Western Australia, 6010, Australia
| | - Rex Woon
- Boston Scientific Neuromodulation, Valencia, CA 91355, USA
| | | | | | - Roshini Jain
- Boston Scientific Neuromodulation, Valencia, CA 91355, USA
| |
Collapse
|
3
|
Antonovich DD, Gama W, Ritter A, Wolf BJ, Nobles RH, Selassie MA, Hillegass MG. Reoperation Rates of Percutaneous and Paddle Leads in Spinal Cord Stimulator Systems: A Single-Center Retrospective Analysis. Pain Med 2021; 22:34-40. [PMID: 32747945 DOI: 10.1093/pm/pnaa215] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
OBJECTIVE We hypothesize that reoperation rates of spinal cord stimulation (SCS) systems utilizing percutaneous leads are comparable to those utilizing paddle leads. We attempt here to characterize causes for those reoperations and identify any related patient characteristics. DESIGN AND SUBJECTS This study is a single-center retrospective chart review of 291 subjects (410 operations) who underwent at least one permanent SCS implantation utilizing percutaneous or paddle leads over a 10-year period at the Medical University of South Carolina. METHODS Charts were reviewed for height, weight, body mass index, gender, race, age, stimulator type, type of reoperation, diabetes status, history and type of prior back surgery, top lead location, and number of leads placed. Comparisons of patient and procedural characteristics were conducted using a two-sample t test (continuous variables), chi-square, or Fisher exact approach (categorical variables). Univariate and multivariate Cox regression models were developed, identifying associations between patient characteristics, SCS characteristics, reoperation rates, and time to reoperation. RESULTS Thirty point five eight percent of subjects (89/291), required at least one reoperation. The reoperation rate was 27.84% for percutaneous systems (N = 54/194) and 27.78% for percutaneous systems (N = 60/216). Time to reoperation also did not differ between the two systems (hazard ratio [HR] = 1.06, 95% CI = 0.70-1.60). Of all factors examined, younger age at time of placement was the only factor associated with risk of reoperation (HR = 0.73, 95% CI = 0.62-0.87, P < 0.001). CONCLUSIONS Our data suggest that reoperation rates and time to reoperation between percutaneous and paddle leads are clinically similar; therefore, rates of reoperation should have no bearing on which system to choose.
Collapse
Affiliation(s)
- Devin D Antonovich
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| | - Willy Gama
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| | - Alexandra Ritter
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| | - Bethany Jacobs Wolf
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| | - Ryan H Nobles
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| | - Meron A Selassie
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| | - M Gabriel Hillegass
- Department of Anesthesia & Perioperative Medicine, The Medical University of South Carolina, Charleston, South Carolina, USA
| |
Collapse
|